Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
1,852 questions in 128 reviews · Effective Practice and Organisation of Care
current versionsNo studies 557 · 30.1%Ungraded 53 · 2.9%Very low 446 · 24.1%Low 476 · 25.7%Moderate 255 · 13.8%High 65 · 3.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Follow‐up integrating additional patient symptom education or monitoring, or survivorship care plans vs usual care Time‐to‐ detection of recurrence · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | no estimate extracted | NR | No studies |
Follow‐up integrating additional patient symptom education or monitoring, or survivorship care plans vs usual care Health‐related quality of life, (HRQoL) · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | no estimate extracted | NR | Very low |
Follow‐up integrating additional patient symptom education or monitoring, or survivorship care plans vs usual care Anxiety · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | no estimate extracted | NR | Very low |
Follow‐up integrating additional patient symptom education or monitoring, or survivorship care plans vs usual care Depression · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | no estimate extracted | NR | Very low |
Follow‐up integrating additional patient symptom education or monitoring, or survivorship care plans vs usual care Cost · adult cancer survivors from the following cancer sites: breast, colorectal, endometrial, ovarian and prostate cancer Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | no estimate extracted | NR | Very low |
Non‐specialist‐led vs specialist‐led follow‐up after primary cancer treatment Time to detection of recurrence · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical,… Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | no estimate extracted | 1691 participants | Very low |
Non‐specialist‐led vs specialist‐led follow‐up after primary cancer treatment Health‐related quality of life, (at 12 months' · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical,… Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | MD 1.06 | 605 participants | Low |
Non‐specialist‐led vs specialist‐led follow‐up after primary cancer treatment Anxiety (at 12 months' · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical,… Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | MD 0.03 | 1266 participants | Moderate |
Non‐specialist‐led vs specialist‐led follow‐up after primary cancer treatment Depression (at 12 months) HADS‐Depression subscale (higher scores indicate worse depression) · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical,… Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | MD 0.03 | 1266 participants | High |
Non‐specialist‐led vs specialist‐led follow‐up after primary cancer treatment Cost · adult cancer survivors from the following cancer sites: breast, colon, colorectal, endometrial, ovarian, cervical,… Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | no estimate extracted | 1756 participants | Very low |
Less intensive vs more intensive follow‐up after primary cancer treatment Overall survival · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma,… Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | HR 1.05 [0.96, 1.14] | 10726 participants | Low |
Less intensive vs more intensive follow‐up after primary cancer treatment Time to detection of recurrence · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma,… Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | HR 0.85 [0.79, 0.92] | 11276 participants | Moderate |
Less intensive vs more intensive follow‐up after primary cancer treatment Health‐related quality of life · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma,… Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors (2019) · Cochrane | no estimate extracted | 2742 participants | Very low |
Proactive ethics consultation vs usual care Decisional conflict · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Request‐based ethics consultation vs usual care Health‐related quality of life · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Request‐based ethics consultation vs usual care Ethical competency · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Request‐based ethics consultation vs usual care Satisfaction with care · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Proactive ethics consultation vs usual care Moral distress · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Proactive ethics consultation vs usual care Patient involvement in decision‐making · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Proactive ethics consultation vs usual care Health‐related quality of life · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Proactive ethics consultation vs usual care Ethical competency · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Proactive ethics consultation vs usual care Satisfaction with care · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | 478 participants | Very low |
Request‐based ethics consultation vs usual care Decisional conflict · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | 62 participants | Very low |
Request‐based ethics consultation vs usual care Moral distress · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Request‐based ethics consultation vs usual care Patient involvement in decision‐making · adult patients (aged > 18 years) Ethical case interventions for adult patients (2019) · Cochrane | no estimate extracted | NR | No studies |
Regulatory policy: use of a prescribing monitoring tool vs no regulatory intervention Medicine use Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | Very low |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs no educational intervention Health care utilization · prescribers or patients that are subjected to regulatory and educational interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs no educational intervention Health outcomes · prescribers or patients that are subjected to regulatory and educational interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs no educational intervention Costs · prescribers or patients that are subjected to regulatory and educational interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Ungraded |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs mailed educational materials on prescribing Medicine use · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Very low |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs mailed educational materials on prescribing Healthcare utilization · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs mailed educational materials on prescribing Health outcomes · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs mailed educational materials on prescribing Costs · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Ungraded |
Educational policy: mailed educational materials on prescribing for physicians only vs an intervention to regulate drug reimbursement Medicine use · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Very low |
Educational policy: mailed educational materials on prescribing for physicians only vs an intervention to regulate drug reimbursement Healthcare utilization · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians only vs an intervention to regulate drug reimbursement Health outcomes · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Regulatory policy: use of a prescribing monitoring tool vs no regulatory intervention Health care utilization Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians only vs an intervention to regulate drug reimbursement Costs · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Ungraded |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs an intervention to regulate drug reimbursement Medicine Use · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Very low |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs an intervention to regulate drug reimbursement Healthcare utilization · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs an intervention to regulate drug reimbursement Health outcomes · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs an intervention to regulate drug reimbursement Costs · prescribers or patients that are subjected to educational or regulatory interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Ungraded |
Regulatory policy: use of a prescribing monitoring tool vs no regulatory intervention Health outcomes Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Regulatory policy: use of a prescribing monitoring tool vs no regulatory intervention Costs Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians vs no educational intervention Medicine use · prescribers or patients that are subjected to educational interventions in prescribing due to government,… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Very low |
Educational policy: mailed educational materials on prescribing for physicians vs no educational intervention Health care utilization · prescribers or patients that are subjected to educational interventions in prescribing due to government,… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians vs no educational intervention Health outcomes · prescribers or patients that are subjected to educational interventions in prescribing due to government,… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | NR | No studies |
Educational policy: mailed educational materials on prescribing for physicians vs no educational intervention Costs · prescribers or patients that are subjected to educational interventions in prescribing due to government,… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Ungraded |
Educational policy: mailed educational materials on prescribing for physicians and HMO members vs no educational intervention Medicine use · prescribers or patients that are subjected to regulatory and educational interventions in prescribing due to… Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers (2019) · Cochrane | no estimate extracted | 1 participants | Very low |
Intervention NR Mortality · all presenting patients in primary care Nurses as substitutes for doctors in primary care (2018) · Cochrane | no estimate extracted | 8 studies · 36529 participants | Low |